HEADER TRANSFERASE/INHIBITOR 17-JAN-12 4DCE TITLE CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH TITLE 2 A PIPERIDINE-CARBOXAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 1078-1410; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS RECEPTOR TYROSINE KINASE, INHIBITOR, NPM-ALK, EML4-ALK, TRANSFERASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.WHITTINGTON,L.F.EPSTEIN,H.CHEN REVDAT 5 03-APR-24 4DCE 1 REMARK REVDAT 4 28-FEB-24 4DCE 1 REMARK SEQADV REVDAT 3 15-NOV-17 4DCE 1 REMARK REVDAT 2 09-MAY-12 4DCE 1 JRNL REVDAT 1 08-FEB-12 4DCE 0 JRNL AUTH M.C.BRYAN,D.A.WHITTINGTON,E.M.DOHERTY,J.R.FALSEY,A.C.CHENG, JRNL AUTH 2 R.EMKEY,R.L.BRAKE,R.T.LEWIS JRNL TITL RAPID DEVELOPMENT OF PIPERIDINE CARBOXAMIDES AS POTENT AND JRNL TITL 2 SELECTIVE ANAPLASTIC LYMPHOMA KINASE INHIBITORS. JRNL REF J.MED.CHEM. V. 55 1698 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22263917 JRNL DOI 10.1021/JM201565S REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 39180 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1972 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2476 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.21 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 154 REMARK 3 BIN FREE R VALUE : 0.3110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4499 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 287 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.60000 REMARK 3 B22 (A**2) : 1.79000 REMARK 3 B33 (A**2) : -1.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.226 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.192 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.143 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.130 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4686 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6353 ; 1.027 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 564 ; 5.236 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 203 ;35.242 ;23.990 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 781 ;13.164 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;16.240 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 688 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3562 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2180 ; 0.182 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3235 ; 0.302 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 284 ; 0.119 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 80 ; 0.174 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 11 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2951 ; 0.799 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4639 ; 1.342 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1992 ; 1.315 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1714 ; 2.197 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4DCE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070153. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39292 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: APO ALK (UNPUBLISHED) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27% PEG 5000 MME, 100 MM MES, 200 MM REMARK 280 AMMONIUM SULFATE, 5 MM DITHIOTHREITOL, PH 6.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 52.40950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 1078 REMARK 465 LYS A 1079 REMARK 465 LEU A 1080 REMARK 465 SER A 1081 REMARK 465 LYS A 1082 REMARK 465 LEU A 1083 REMARK 465 ARG A 1084 REMARK 465 THR A 1085 REMARK 465 SER A 1086 REMARK 465 THR A 1087 REMARK 465 ILE A 1088 REMARK 465 MET A 1089 REMARK 465 THR A 1090 REMARK 465 ASP A 1091 REMARK 465 TYR A 1092 REMARK 465 GLY A 1125 REMARK 465 ALA A 1126 REMARK 465 PHE A 1127 REMARK 465 GLY A 1137 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 MET A 1273 REMARK 465 ALA A 1274 REMARK 465 ARG A 1275 REMARK 465 ASP A 1276 REMARK 465 ILE A 1277 REMARK 465 TYR A 1278 REMARK 465 ARG A 1279 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 465 GLU A 1408 REMARK 465 GLU A 1409 REMARK 465 LYS A 1410 REMARK 465 TYR B 1078 REMARK 465 LYS B 1079 REMARK 465 LEU B 1080 REMARK 465 SER B 1081 REMARK 465 LYS B 1082 REMARK 465 LEU B 1083 REMARK 465 ARG B 1084 REMARK 465 THR B 1085 REMARK 465 SER B 1086 REMARK 465 THR B 1087 REMARK 465 ILE B 1088 REMARK 465 MET B 1089 REMARK 465 THR B 1090 REMARK 465 ASP B 1091 REMARK 465 TYR B 1092 REMARK 465 ASN B 1093 REMARK 465 GLY B 1125 REMARK 465 ALA B 1126 REMARK 465 PHE B 1127 REMARK 465 GLY B 1128 REMARK 465 GLY B 1137 REMARK 465 MET B 1138 REMARK 465 PRO B 1139 REMARK 465 ASN B 1140 REMARK 465 ASP B 1141 REMARK 465 PRO B 1142 REMARK 465 MET B 1273 REMARK 465 ALA B 1274 REMARK 465 ARG B 1275 REMARK 465 ASP B 1276 REMARK 465 ILE B 1277 REMARK 465 TYR B 1278 REMARK 465 ARG B 1279 REMARK 465 ALA B 1280 REMARK 465 SER B 1281 REMARK 465 TYR B 1282 REMARK 465 TYR B 1283 REMARK 465 ARG B 1284 REMARK 465 LYS B 1285 REMARK 465 GLY B 1286 REMARK 465 GLY B 1287 REMARK 465 PRO B 1403 REMARK 465 LEU B 1404 REMARK 465 VAL B 1405 REMARK 465 GLU B 1406 REMARK 465 GLU B 1407 REMARK 465 GLU B 1408 REMARK 465 GLU B 1409 REMARK 465 LYS B 1410 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1248 -10.33 85.77 REMARK 500 ASP A1249 56.00 -148.37 REMARK 500 MET A1302 -93.70 -85.52 REMARK 500 LEU B1122 -76.39 -121.62 REMARK 500 ARG B1248 -14.30 83.87 REMARK 500 ASP B1249 52.27 -143.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0JF A 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0JF B 1501 DBREF 4DCE A 1078 1410 UNP Q9UM73 ALK_HUMAN 1078 1410 DBREF 4DCE B 1078 1410 UNP Q9UM73 ALK_HUMAN 1078 1410 SEQADV 4DCE SER A 1097 UNP Q9UM73 CYS 1097 ENGINEERED MUTATION SEQADV 4DCE SER B 1097 UNP Q9UM73 CYS 1097 ENGINEERED MUTATION SEQRES 1 A 333 TYR LYS LEU SER LYS LEU ARG THR SER THR ILE MET THR SEQRES 2 A 333 ASP TYR ASN PRO ASN TYR SER PHE ALA GLY LYS THR SER SEQRES 3 A 333 SER ILE SER ASP LEU LYS GLU VAL PRO ARG LYS ASN ILE SEQRES 4 A 333 THR LEU ILE ARG GLY LEU GLY HIS GLY ALA PHE GLY GLU SEQRES 5 A 333 VAL TYR GLU GLY GLN VAL SER GLY MET PRO ASN ASP PRO SEQRES 6 A 333 SER PRO LEU GLN VAL ALA VAL LYS THR LEU PRO GLU VAL SEQRES 7 A 333 CYS SER GLU GLN ASP GLU LEU ASP PHE LEU MET GLU ALA SEQRES 8 A 333 LEU ILE ILE SER LYS PHE ASN HIS GLN ASN ILE VAL ARG SEQRES 9 A 333 CYS ILE GLY VAL SER LEU GLN SER LEU PRO ARG PHE ILE SEQRES 10 A 333 LEU LEU GLU LEU MET ALA GLY GLY ASP LEU LYS SER PHE SEQRES 11 A 333 LEU ARG GLU THR ARG PRO ARG PRO SER GLN PRO SER SER SEQRES 12 A 333 LEU ALA MET LEU ASP LEU LEU HIS VAL ALA ARG ASP ILE SEQRES 13 A 333 ALA CYS GLY CYS GLN TYR LEU GLU GLU ASN HIS PHE ILE SEQRES 14 A 333 HIS ARG ASP ILE ALA ALA ARG ASN CYS LEU LEU THR CYS SEQRES 15 A 333 PRO GLY PRO GLY ARG VAL ALA LYS ILE GLY ASP PHE GLY SEQRES 16 A 333 MET ALA ARG ASP ILE TYR ARG ALA SER TYR TYR ARG LYS SEQRES 17 A 333 GLY GLY CYS ALA MET LEU PRO VAL LYS TRP MET PRO PRO SEQRES 18 A 333 GLU ALA PHE MET GLU GLY ILE PHE THR SER LYS THR ASP SEQRES 19 A 333 THR TRP SER PHE GLY VAL LEU LEU TRP GLU ILE PHE SER SEQRES 20 A 333 LEU GLY TYR MET PRO TYR PRO SER LYS SER ASN GLN GLU SEQRES 21 A 333 VAL LEU GLU PHE VAL THR SER GLY GLY ARG MET ASP PRO SEQRES 22 A 333 PRO LYS ASN CYS PRO GLY PRO VAL TYR ARG ILE MET THR SEQRES 23 A 333 GLN CYS TRP GLN HIS GLN PRO GLU ASP ARG PRO ASN PHE SEQRES 24 A 333 ALA ILE ILE LEU GLU ARG ILE GLU TYR CYS THR GLN ASP SEQRES 25 A 333 PRO ASP VAL ILE ASN THR ALA LEU PRO ILE GLU TYR GLY SEQRES 26 A 333 PRO LEU VAL GLU GLU GLU GLU LYS SEQRES 1 B 333 TYR LYS LEU SER LYS LEU ARG THR SER THR ILE MET THR SEQRES 2 B 333 ASP TYR ASN PRO ASN TYR SER PHE ALA GLY LYS THR SER SEQRES 3 B 333 SER ILE SER ASP LEU LYS GLU VAL PRO ARG LYS ASN ILE SEQRES 4 B 333 THR LEU ILE ARG GLY LEU GLY HIS GLY ALA PHE GLY GLU SEQRES 5 B 333 VAL TYR GLU GLY GLN VAL SER GLY MET PRO ASN ASP PRO SEQRES 6 B 333 SER PRO LEU GLN VAL ALA VAL LYS THR LEU PRO GLU VAL SEQRES 7 B 333 CYS SER GLU GLN ASP GLU LEU ASP PHE LEU MET GLU ALA SEQRES 8 B 333 LEU ILE ILE SER LYS PHE ASN HIS GLN ASN ILE VAL ARG SEQRES 9 B 333 CYS ILE GLY VAL SER LEU GLN SER LEU PRO ARG PHE ILE SEQRES 10 B 333 LEU LEU GLU LEU MET ALA GLY GLY ASP LEU LYS SER PHE SEQRES 11 B 333 LEU ARG GLU THR ARG PRO ARG PRO SER GLN PRO SER SER SEQRES 12 B 333 LEU ALA MET LEU ASP LEU LEU HIS VAL ALA ARG ASP ILE SEQRES 13 B 333 ALA CYS GLY CYS GLN TYR LEU GLU GLU ASN HIS PHE ILE SEQRES 14 B 333 HIS ARG ASP ILE ALA ALA ARG ASN CYS LEU LEU THR CYS SEQRES 15 B 333 PRO GLY PRO GLY ARG VAL ALA LYS ILE GLY ASP PHE GLY SEQRES 16 B 333 MET ALA ARG ASP ILE TYR ARG ALA SER TYR TYR ARG LYS SEQRES 17 B 333 GLY GLY CYS ALA MET LEU PRO VAL LYS TRP MET PRO PRO SEQRES 18 B 333 GLU ALA PHE MET GLU GLY ILE PHE THR SER LYS THR ASP SEQRES 19 B 333 THR TRP SER PHE GLY VAL LEU LEU TRP GLU ILE PHE SER SEQRES 20 B 333 LEU GLY TYR MET PRO TYR PRO SER LYS SER ASN GLN GLU SEQRES 21 B 333 VAL LEU GLU PHE VAL THR SER GLY GLY ARG MET ASP PRO SEQRES 22 B 333 PRO LYS ASN CYS PRO GLY PRO VAL TYR ARG ILE MET THR SEQRES 23 B 333 GLN CYS TRP GLN HIS GLN PRO GLU ASP ARG PRO ASN PHE SEQRES 24 B 333 ALA ILE ILE LEU GLU ARG ILE GLU TYR CYS THR GLN ASP SEQRES 25 B 333 PRO ASP VAL ILE ASN THR ALA LEU PRO ILE GLU TYR GLY SEQRES 26 B 333 PRO LEU VAL GLU GLU GLU GLU LYS HET 0JF A1501 36 HET 0JF B1501 36 HETNAM 0JF (3S)-N-(4-METHYLBENZYL)-1-{2-[(3,4,5-TRIMETHOXYPHENYL) HETNAM 2 0JF AMINO]PYRIMIDIN-4-YL}PIPERIDINE-3-CARBOXAMIDE FORMUL 3 0JF 2(C27 H33 N5 O4) FORMUL 5 HOH *287(H2 O) HELIX 1 1 SER A 1104 LEU A 1108 5 5 HELIX 2 2 PRO A 1112 LYS A 1114 5 3 HELIX 3 3 SER A 1157 PHE A 1174 1 18 HELIX 4 4 LEU A 1204 THR A 1211 1 8 HELIX 5 5 ALA A 1222 ASN A 1243 1 22 HELIX 6 6 ALA A 1251 ARG A 1253 5 3 HELIX 7 7 PRO A 1292 MET A 1296 5 5 HELIX 8 8 PRO A 1297 MET A 1302 1 6 HELIX 9 9 THR A 1307 SER A 1324 1 18 HELIX 10 10 SER A 1334 SER A 1344 1 11 HELIX 11 11 PRO A 1355 TRP A 1366 1 12 HELIX 12 12 GLN A 1369 ARG A 1373 5 5 HELIX 13 13 ASN A 1375 GLN A 1388 1 14 HELIX 14 14 ASP A 1389 ASN A 1394 1 6 HELIX 15 15 SER B 1106 LEU B 1108 5 3 HELIX 16 16 PRO B 1112 LYS B 1114 5 3 HELIX 17 17 SER B 1157 PHE B 1174 1 18 HELIX 18 18 LEU B 1204 ARG B 1212 1 9 HELIX 19 19 ALA B 1222 ASN B 1243 1 22 HELIX 20 20 ALA B 1251 ARG B 1253 5 3 HELIX 21 21 PRO B 1292 MET B 1296 5 5 HELIX 22 22 PRO B 1297 GLY B 1304 1 8 HELIX 23 23 THR B 1307 SER B 1324 1 18 HELIX 24 24 SER B 1334 SER B 1344 1 11 HELIX 25 25 PRO B 1355 TRP B 1366 1 12 HELIX 26 26 GLN B 1369 ARG B 1373 5 5 HELIX 27 27 ASN B 1375 ASP B 1389 1 15 HELIX 28 28 ASP B 1389 ASN B 1394 1 6 SHEET 1 A 2 TYR A1096 PHE A1098 0 SHEET 2 A 2 LYS A1101 SER A1103 -1 O SER A1103 N TYR A1096 SHEET 1 B 5 ILE A1116 GLY A1123 0 SHEET 2 B 5 VAL A1130 VAL A1135 -1 O GLU A1132 N ARG A1120 SHEET 3 B 5 LEU A1145 THR A1151 -1 O VAL A1147 N GLY A1133 SHEET 4 B 5 PHE A1193 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 B 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 C 3 GLY A1202 ASP A1203 0 SHEET 2 C 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 C 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 SHEET 1 D 2 ASN B1095 PHE B1098 0 SHEET 2 D 2 LYS B1101 SER B1104 -1 O SER B1103 N TYR B1096 SHEET 1 E 5 ILE B1116 GLY B1121 0 SHEET 2 E 5 VAL B1130 VAL B1135 -1 O GLU B1132 N ARG B1120 SHEET 3 E 5 LEU B1145 THR B1151 -1 O VAL B1149 N TYR B1131 SHEET 4 E 5 PHE B1193 GLU B1197 -1 O LEU B1196 N ALA B1148 SHEET 5 E 5 CYS B1182 SER B1186 -1 N GLY B1184 O LEU B1195 SHEET 1 F 3 GLY B1202 ASP B1203 0 SHEET 2 F 3 CYS B1255 LEU B1257 -1 O LEU B1257 N GLY B1202 SHEET 3 F 3 ALA B1266 ILE B1268 -1 O LYS B1267 N LEU B1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -1.29 CISPEP 2 LEU B 1190 PRO B 1191 0 -2.32 SITE 1 AC1 15 LEU A1122 ALA A1148 LYS A1150 GLU A1167 SITE 2 AC1 15 ILE A1171 ILE A1179 VAL A1180 GLU A1197 SITE 3 AC1 15 MET A1199 ALA A1200 GLY A1202 LEU A1256 SITE 4 AC1 15 GLY A1269 ASP A1270 PHE A1271 SITE 1 AC2 16 LEU B1122 VAL B1130 ALA B1148 LYS B1150 SITE 2 AC2 16 ILE B1171 LEU B1196 GLU B1197 MET B1199 SITE 3 AC2 16 ALA B1200 GLY B1202 ASP B1203 LEU B1256 SITE 4 AC2 16 GLY B1269 ASP B1270 PHE B1271 HOH B1673 CRYST1 51.612 104.819 57.817 90.00 90.15 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019375 0.000000 0.000049 0.00000 SCALE2 0.000000 0.009540 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017296 0.00000